Responses
EULAR 2014: Scientific Abstracts
Oral Presentations. Update on classification and management of myositis
OP0290 Long Time Experience with Rituximab in the Antisynthetase Syndrome with Severe Lung Disease
Compose a Response to This Article
Other responses
No responses have been published for this article.